All Stories

  1. Opportunistic and Organized Cervical Cancer Screening: Impact on Lesion Severity and Surgical Outcomes in 9830 Cervical Conizations
  2. Partner treatment in women with bacterial vaginosis: an update to the International Society for the Study of Vulvovaginal Disease (ISSVD) recommendations
  3. Human Papillomavirus Testing and Size of CIN3: Implications for the Risk of Microinvasive Cervical Carcinoma
  4. MICROSCOPY ATLAS | ISSVD PRACTICAL GUIDE TO DIAGNOSIS AND MANAGEMENT
  5. The future of research on vulvar intraepithelial neoplasia: towards precision diagnostics and risk stratification
  6. Current practices in HPV-related anogenital neoplasia care in Europe – a survey analysis
  7. The challenging approach to the management of male partners of HPV-positive women
  8. Imiquimod for Anal High Grade Intraepithelial Neoplasia: A Systematic Review
  9. What Are Consumers Looking for With Boric Acid?
  10. Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European ...
  11. Will artificial intelligence be the answer for the gap in vulvovaginal diseases?
  12. When did the confusion between vulvodynia and vaginismus start?
  13. Polymicrobial Consortia in the Pathogenesis of Biofilm Vaginosis Visualized by FISH. Historic Review Outlining the Basic Principles of the Polymicrobial Infection Theory
  14. Vulvar Inspection During Cervical Cancer Screening Procedures: The Ugly Reality
  15. Evaluation of Host Gene Methylation as a Triage Test for HPV–Positive Women—A Cohort Study
  16. Performance of Different Follow-Up Strategies and Genotype-Based Recurrence Risk After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
  17. The genital tract microbiome: bridging the gap between hype and clinical reality
  18. Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological cancer prevention: review of the current evidence, the European Society of Gynaecological Oncology prevention committee statement
  19. Is Vulvodynia Associated With an Altered Vaginal Microbiota?: A Systematic Review
  20. The International Society for the Study of Vulvovaginal Disease (ISSVD) Vulvar Awareness Day Campaign: Knowledge of Vulvovaginal Diseases Among Italian Obstetrics and Gynecology Residents
  21. Genital and extragenital oncological risk in women with vulvar lichen sclerosus: A multi-center Italian study
  22. Chlamydial and Gonococcal Genital Infections: A Narrative Review
  23. Low genitourinary tract risks in women living with the human immunodeficiency virus
  24. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus St...
  25. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus st...
  26. Vulvar High-Grade Squamous Intraepithelial Lesion and the Risk of Recurrence and Progression to Cancer
  27. Scoping review of cytolytic vaginosis literature
  28. International Society for the Study of Vulvovaginal Disease Recommendations for the Diagnosis and Treatment of Vaginitis
  29. Chronic Hypertrophic Herpes Simplex Infection: A 13-Year Delay
  30. Therapeutic Options for Chlamydia trachomatis Infection: Present and Future
  31. Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”
  32. Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review
  33. Vulvar Paget's disease: outcomes of 51 patients treated with imiquimod cream
  34. Vaginal Leptothrix: An Innocent Bystander?
  35. Changes in the Vaginal Microbiota of Women With Secondary Localized Provoked Vulvodynia
  36. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus sta...
  37. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Sta...
  38. Early Diagnostics of Vulvar Intraepithelial Neoplasia
  39. Wet Mount Microscopy of the Vaginal Milieu Does Not Predict the Outcome of Fertility Treatments: A Cross-sectional Study: Erratum
  40. Risk Factors for Positive Margins in High-Grade Cervical Intraepithelial Neoplasia After Transformation Zone Excision
  41. Risk of Development of Vulvar Cancer in Women With Lichen Sclerosus or Lichen Planus: A Systematic Review
  42. Wet Mount Microscopy of the Vaginal Milieu Does Not Predict the Outcome of Fertility Treatments
  43. COVID-19 related acute genital ulcer: a case report
  44. The Vaginal Microbiome: I. Research Development, Lexicon, Defining “Normal” and the Dynamics Throughout Women's Lives
  45. The Vaginal Microbiome: II. Vaginal Dysbiotic Conditions
  46. The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders
  47. The Vaginal Microbiome: IV. The Role of Vaginal Microbiome in Reproduction and in Gynecologic Cancers
  48. The Vaginal Microbiome: V. Therapeutic Modalities of Vaginal Microbiome Engineering and Research Challenges
  49. Vulvar High-Grade Squamous Intraepithelial Lesions and Cancer as a Risk Factor for Anal Cancer: A Review
  50. Use of Moisturizers and Lubricants for Vulvovaginal Atrophy
  51. Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
  52. Genitourinary Syndrome of Menopause: Epidemiology, Physiopathology, Clinical Manifestation and Diagnostic
  53. Surgical treatment for provoked vulvodynia – Where do we stand? A narrative review
  54. G-spot: Fact or Fiction?: A Systematic Review
  55. Superficially Invasive Vulvar Squamous Cell Carcinoma: A 37-Year-Long Experience of a Tertiary Referral Center
  56. Diagnosis of bacterial vaginosis: Clinical or microscopic? A cross‐sectional study
  57. Cytology Is Not Reliable to Evaluate Cervical Disease Regression
  58. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease
  59. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy
  60. For Anal Cancer, Not All Women Are Equal
  61. Clinical validation of a new molecular test (Seegene Allplex™ Vaginitis) for the diagnosis of vaginitis: a cross‐sectional study
  62. Clarification about vulvar cancer precursor lesions
  63. The International Society for the Study of Vulvovaginal Disease Vaginal Wet Mount Microscopy Guidelines: How to Perform, Applications, and Interpretation
  64. Knowledge of Vulvar Anatomy and Self-examination in a Sample of Italian Women
  65. Letter to the editor: “Do variations in labial anatomy have an effect on recurrent urinary tract infection?”
  66. Erosive Vulvar Lichen Planus and Risk of Vulvar Neoplasia
  67. Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer
  68. Cross-Protective IgG and IgA Antibodies against Oncogenic and Non-Oncogenic HPV Genotypes
  69. Impact of a High Coverage Vaccination Rate on Human Papillomavirus Infection Prevalence in Young Women: A Cross-sectional Study
  70. Better studies needed on LASER use in urinary incontinence
  71. Prognostic factors in patients with vulvar cancer: the VULCAN study
  72. Editorial Comment: The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  73. Better triage tests needed for HPV‐positive women
  74. Adult Vulvar Lichen Sclerosus: Can Experts Agree on the Assessment of Disease Severity?
  75. Corrigendum
  76. The International Classification of Diseases, 11th Revision: A Step-Back for Women With Vulvodynia?
  77. Diagnosis of vaginitis: time to improve and move on
  78. Response letter to comments related to “The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document”
  79. Systematic review and meta-analysis of the effects of treatment modalities for vestibulodynia in women
  80. Vulvodynia: a neglected chronic pain diagnosis
  81. Academic cosmetic gynaecology and energy-based therapies: ambiguities, explorations, and FDA advisories
  82. Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society)
  83. Impact of the Sampling Site in the Result of Wet Mount Microscopy
  84. The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: An ICS/ISSVD Best Practice Consensus Document
  85. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  86. The energy based devices for vaginal “rejuvenation,” urinary incontinence, vaginal cosmetic procedures, and other vulvo‐vaginal disorders: An international multidisciplinary expert panel opinion
  87. Immediate Loop Electrode Excisional Procedure for High-Grade Cervical Cytology: One Size Fits All?
  88. Vulvodynia: A disease commonly hidden in plain sight
  89. International Society for the Study of Vulvovaginal Disease Recommendations Regarding Female Cosmetic Genital Surgery
  90. To the Editor:
  91. Bioengineering Organs for Blood Detoxification
  92. The ReCiDiF method to treat recurrent vulvovaginal candidosis: A friend with benefits
  93. Diagnosis and management of vulvodynia in postmenopausal women
  94. Aerobic vaginitis: no longer a stranger
  95. Clinical Validation of a Test for the Diagnosis of Vaginitis: Correction
  96. Clinical Validation of a Test for the Diagnosis of Vaginitis
  97. Lichen sclerosus in women: a review
  98. Survey on Aesthetic Vulvovaginal Procedures: What do Portuguese Doctors and Medical Students Think?
  99. Women without vulvodynia can have a positive ‘Q-tip test’: a cross sectional study
  100. P-04-003 Prevalence of Sexually Transmitted Diseases Among Women in Principe Island
  101. Deconstructing the genitourinary syndrome of menopause
  102. Genital Tract Infections in an Isolated Community: 100 Women of the Príncipe Island
  103. Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504)
  104. Is the DSM-V Leading to the Nondiagnosis of Vulvodynia?
  105. Lipschütz ulcers: should we rethink this? An analysis of 33 cases
  106. Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV-positive women
  107. Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities
  108. The “Genitourinary Syndrome of Menopause”
  109. Emphysematous Vaginitis
  110. What Differentiates Symptomatic from Asymptomatic Women with Lichen Sclerosus?
  111. Prevalence of vulvodynia and risk factors for the condition in Portugal
  112. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism
  113. Mycoplasma pneumoniae
  114. Lichen Sclerosus in Breast Cancer Survivor
  115. Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman
  116. Sclerosing stromal tumour of the ovary associated with Meigs' syndrome and elevated CA125
  117. Case report: intra-partum utero-ovarian vessels rupture
  118. Use of extensible internal device in the femur of young dogs
  119. L-band land mobile satellite (LMS) amplitude and multipath phase modeling in urban areas
  120. Mobile and Base Station Diversity Simulation Experiments in a Mobile Communications Course